Skip to Content

Asian Tribune is published by World Institute For Asian Studies|Powered by WIAS Vol. 12 No. 2829

Life & Health

ICPS Roll out in Uttar Pradesh Possible within the next three months?

The Integrated Child Protection Scheme (ICPS) is a much awaited initiative in Uttar Pradesh. And rightly so with hopes of both, the government agencies as well as the private NGOs and activists pinned on the scheme for a better, safer and a more organized system of ushering in a protective environment for children in the state. Once implemented the ICPS is being touted as the ultimate accountability apparatus for care and protection as well as an effective juvenile justice system in the state.

No getting to zero new HIV infections in ASEAN without women

Young women, female sex workers, transgender women, women who use drugs and women living with HIV have called on ASEAN to support women and girls living with and affected by HIV.

Charcot Foot In Diabetes: An Enigma

Charcot neuropathic osteo-arthropathy, commonly referred to as the Charcot Foot, is a condition affecting the bones, joints, and soft tissues of the foot and ankle. The disorder was first brought to the world’s attention in 1983 by Dr Jean Martin Charcot when he referred to the disease process as a complication of syphilis in the knee joint in his patient.

Look At Your Feet And Listen To Them

A three day Amrita Endocrinology, Diabetes and Diabetic Foot Conference (AEDFC 2012) was recently held in Kochi at the Amrita Institute of Medical Sciences (AIMS). It brought together clinicians, surgeons and researchers from across the country and the world to re-energize the grey cells and deliberate upon various problems related to endocrinology and diabetes, with special emphasis on the management of diabetic foot infections, which could so often be life/limb threatening and yet are largely misunderstood and/or ignored by the public as well as medical fraternity.

Comprehensive and integrated action must to control heart disease

Cardiovascular diseases (CVDs) are the world's largest killers, claiming 17.3 million (1 crore 73 lakhs) lives a year. Risk factors for heart disease and stroke include raised blood pressure, cholesterol and glucose levels, smoking, inadequate intake of fruit and vegetables, overweight, obesity and physical inactivity.

Voluntary Medical Male Circumcision partially protects against HIV, HPV and Herpes

Modeling based on a timeline where 80 percent coverage of Voluntary Medical Male Circumcision (VMMC) of men age 15-49 is achieved by 2015 suggests that more than 20 percent of new HIV infections would be averted by 2025, with financial savings of an estimated USD 16.6 billion in future medical costs, said Cindra Feuer, Communications and Policy Advisor, AVAC - Global Advocacy for HIV Prevention at AIDS Vaccine 2012.

An HIV vaccine will never work in isolation

In the event that control and elimination of HIV is realised in the next few years, maintaining this success is going to be hard without a vaccine. That is how the Director of the US’ National Institutes of Allergy and Infectious Disease Dr Anthony Fauci analysed the situation at the AIDS Vaccine 2012 conference which ended Wednesday (Sept.12) in the American city of Boston.

Vaccines: Final Nail In HIV Coffin?

HIV is said to have killed more than 30 million people across the globe since it was discovered in 1983 by Dr Francoise Barre-Sinoussi, at the Pasteur Institute in Paris.

Celebrating The First Ever Global Female Condom Day

For the first time ever, people from all over the world will observe Global Female Condom Day on Wednesday, 12th September 2012. The Chicago Female Condom Campaign will help lead the way calling for greater access to, and increased education on the importance of female condoms.

Vaginal Microbicide offers hope for partial anti-HIV protection

There are clear reasons why the vaginal microbicide research and development offers more hope in 2012. Vaginal microbicide (anti-HIV gel) research is going ahead and scientists are waiting for study results to tell them more whether the CAPRISA-004 study results that reported 39% overall efficacy for women in July 2010 can be replicated in another study called FACTS-001, and if so, is the evidence strong enough for licensure.

Syndicate content


.